Volume 12, Issue 9 p. 766-771

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

C. J. Girman

Corresponding Author

C. J. Girman

Epidemiology, Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, North Wales, PA, USA

Cynthia J. Girman, Epidemiology, Clinical and Quantitative Sciences, Merck Research Laboratories, PO BOX 1000, North Wales, PA 19454, USA.
E-mail: cindy_girman@merck.comSearch for more papers by this author
T. D. Kou

T. D. Kou

Epidemiology, Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, North Wales, PA, USA

Search for more papers by this author
B. Cai

B. Cai

Epidemiology, Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, North Wales, PA, USA

Search for more papers by this author
C. M. Alexander

C. M. Alexander

Global Medical Affairs, Merck, North Wales, PA, USA

Search for more papers by this author
E. A. O’Neill

E. A. O’Neill

Medical Communications, Merck Research Laboratories, Rahway, NJ, USA

Search for more papers by this author
D. E. Williams-Herman

D. E. Williams-Herman

Metabolism, Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, Rahway, NJ, USA

Search for more papers by this author
L. Katz

L. Katz

Metabolism, Global Clinical Development and Regulatory Affairs, Merck Research Laboratories, Rahway, NJ, USA

Search for more papers by this author
First published: 23 July 2010
Citations: 149

Abstract

Aim: The aetiology of acute pancreatitis (AP) is complex, and many risk factors for AP are shared by patients with type 2 diabetes mellitus (T2DM). However, few have assessed risk factors for AP specifically in T2DM patients.

Methods: Patients in the General Practice Research Database (2 984 755, 5.0% with T2DM) were used to estimate incidence of AP for T2DM relative to non-diabetes, adjusting for prior pancreatitis, gallbladder disease, obesity, smoking and alcohol use. Multivariate Cox regression analysis adjusting for risk factors and Charlson comorbidity index (CCI) was used to estimate hazard ratios (HR) with 95% confidence intervals (CI).

Results: Between 2003 and 2007, 301 of 148 903 patients with T2DM and 2434 of almost 3 million patients without diabetes developed AP. Patients with T2DM had higher risk for AP compared with patients without diabetes (crude HR: 2.89, 95% CI: 2.56–3.27). Patients with T2DM had significantly higher rates of prior alcohol and tobacco exposure (44.2 and 61.9% vs. 34.1 and 35.9%, p < 0.001) and of comorbid conditions (14.7% with CCI ≥1 vs. 4.3%, p < 0.001). Histories of obesity, pancreatitis, gallbladder disease, smoking or alcohol use were significant predictors of AP. After adjusting for these factors, age, gender and comorbidities, the risk of developing AP remained elevated in patients with T2DM (adjusted HR: 1.49, 95% CI: 1.31–1.70).

Conclusion: After adjusting for risk factors, patients with T2DM had an elevated risk of AP compared with patients without diabetes. Physicians should be aware of the increased risk in patients with T2DM, particularly in those with prior pancreatitis.